4//SEC Filing
AMAG PHARMACEUTICALS INC. 4
Accession 0001179110-14-000628
CIK 0000792977operating
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:54 PM ET
Size
8.0 KB
Accession
0001179110-14-000628
Insider Transaction Report
Form 4
White Christopher G
Chief Business Officer and SVP
Transactions
- Sale
Common Stock
2014-01-07$24.10/sh−2,500$60,250→ 28,834 total - Sale
Common Stock
2014-01-06$23.69/sh−2,500$59,225→ 31,334 total
Footnotes (4)
- [F1]The shares reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person.
- [F2]The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $23.30 - $23.95. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc., or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.
- [F3]This total includes 5,000 shares delivered to the reporting person on January 3, 2014 pursuant to the partial vesting of a restricted stock unit award granted to the reporting person on January 3, 2012 and of which 2,500 shares were sold on January 6, 2014 as reported in this Form 4. This total also includes 834 unvested restricted stock units granted on February 24, 2010, 8,000 unvested restricted stock units granted pursuant to two separate grants on January 7, 2011, and 5,000 unvested restricted stock units granted on January 3, 2012, all of which were previously reported on Table II. Thus, after taking into account the delivery of shares on January 3, 2014, this total includes an aggregate of 18,834 unvested restricted stock units previously reported on Table II.
- [F4]The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $23.84 - $24.82. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc., or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.
Documents
Issuer
AMAG PHARMACEUTICALS INC.
CIK 0000792977
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000792977
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 4:54 PM ET
- Size
- 8.0 KB